Stelara Biosimilars Coming to the Prescription Plan in 2026 Stelara (ustekinumab) is an injectable prescription medicine used to treat inflammatory conditions and has high utilization on the prescription plan. Starting January 1, 2026, brand-name Stelara will move to non-formulary status, and MedImpact will prefer the following FDA-approved biosimilars: … [Read more...] about Important RX Plan Update
MedImpact/Elixir is currently experiencing a system outage that began on October 18, 2025, impacting their legacy Elixir claims adjudication platform. This disruption has affected the ability of pharmacies to process eligibility verifications and claims in real time. MedImpact has confirmed that system restoration and data integrity remain their highest priorities, and some … [Read more...] about Notice Regarding Prescription Processing Delays
Celebrate World Hypertension Day: Take Control of Your Blood Pressure Hypertension, or high blood pressure, is often called the "silent killer" because it typically has no symptoms but can lead to serious health complications. This year, World Hypertension Day focuses on the theme: "Measure Your Blood Pressure Accurately, Control It, Live Longer!" Join on May 17, 2025, to … [Read more...] about World Hypertension Day: May 17th